1. GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, UK;2. GlaxoSmithKline Research and Development, Upper Merion, PA, USA
Abstract:
Optimisation of a series of biaryl sulphonamides resulted in the identification of compound 7 which demonstrated dose-dependent and strain-specific inhibition of monocyte recruitment in a thioglycollate-induced peritonitis model of inflammation.